The brief

Analyst view

• 816 robots installed in the US at 30 June 2026; Q2 2026 revenue $94.5M, up 19%, with US procedures up about 21%.
• 2026 guidance: $390-410M revenue and 54,000-56,000 US procedures, still loss-making.
• Now testing Aquablation for prostate cancer; first randomized results due spring 2027.

Technical approach

As reported

Waterjet

Cut with water, not heat

A high-pressure waterjet removes prostate tissue without heat, avoiding the thermal damage behind many side effects of older surgery.

Imaging

Plan on live ultrasound

The surgeon maps the prostate on real-time ultrasound and a camera view, marking what to remove and what to spare.

Robot

The robot executes the plan

Once the plan is set, the robot moves the waterjet itself to remove tissue consistently, so results depend less on a surgeon's hand.

Razor-blade

Robot sale plus a disposable per case

Hospitals buy the robot (about $495,000 for a new HYDROS) and a single-use handpiece (about $3,550) for each procedure.

Show all 4